- Arrhythmogenic right ventricular cardiomyopathy
- Family history of sudden cardiac death
- Hypertrophic cardiomyopathy (HCM)
- Inherited cardiomyopathy
- Genetic testing
Alejandro Eduardo De Feria Alsina, MD
Cardiology
Accepting new patients
Sees patients age 18 and up
Penn Heart and Vascular Center
Penn Medicine Provider
About me
- Assistant Professor of Clinical Medicine (Cardiovascular Medicine)
My education and training
- Medical School: Vanderbilt University Medical Center
- Residency: Massachusetts General Hospital/Brigham and Women’s Hospital
- Fellowship: University of Pennsylvania Health System
Spoken languages
English
English
Reviews
456 reviews
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Insurance accepted
Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Amerihealth of NJ Core
- Amerihealth of NJ Enhanced
- Amerihealth of NJ HMO
- Amerihealth of NJ Local Value
- Amerihealth of NJ POS
- Amerihealth of NJ PPO
- Amerihealth of NJ Regional Preferred
- Amerihealth of NJ Secure
- Amerihealth of NJ Ultimate (PPO)
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
Locations
Qualifications and experience
- Cardiovascular Disease, 2021
- Internal Medicine, 2018
- American College of Cardiology, National
- American Heart Association, National
- American Heart Association, National
- American Medical Association, National
- Hypertrophic Cardiomyopathy Association, National
- Penn Center for Inherited Cardiovascular Disease
Treatments and conditions
Research
Publications
Shad R, Zakka C, Kaur D, Mathur M, Fong R, Cho J, Filice RW, Mongan J, Kallianos K, Khandwala N, Eng D, Leipzig M, Witschey WR, de Feria A, Ferrari VA, Ashley EA, Acker MA, Langlotz C, Hiesinger W. A Generalizable Deep Learning System for Cardiac MRI , Nature Biomedical Engineering: 2026
Reza N, Mahmud N, Austin MA, Duqueney E, Patel P, Boakye E, Hornsby N, DE Feria A, Marzolf A, Owens AT. Antihypertensive Dosing During Mavacamten Therapy for Obstructive Hypertrophic Cardiomyopathy , Journal of Cardiac Failure Intersections: 2026
Reza N, Mahmud N, Austin MA, Boakye E, Duqueney E, Patel P, DE Feria A, Hornsby N, Marzolf A, Owens AT. Association Between Baseline Hypertension and Longitudinal Functional Status in Obstructive Hypertrophic Cardiomyopathy Treated with Mavacamten , Journal of Cardiac Failure: 2026
Reza N, Mahmud N, Austin MA, Duqueney E, Patel P, Boakye E, Hornsby N, de Feria A, Marzolf A, Owens AT. Hypertension in Patients With Obstructive Hypertrophic Cardiomyopathy Treated with Mavacamten , JACC Heart Failure: 2025
Reza N, Dubey A, Mahmud N, Austin MA, Duqueney E, Patel P, Boakye E, Marzolf A, Hornsby N, de Feria A, Carattini T, Schuler P, Owens AT. Long Term Real World Outcomes of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy up to 108 Weeks , Journal of Clinical Medicine: 2025
Reza N, Mahmud N, Austin MA, Duqueney E, Patel P, Boakye E, Hornsby N, de Feria A, Marzolf A, Owens AT. Hypertension in Patients With Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten , JACC Heart Failure: 2025
Thomas A Boyle, Nosheen Reza, Matthew Hyman, Gregory Supple, Vincent Y See, Amy Marzolf, Nicole Hornsby, Alejandro de Feria, Teresa Wang, Kenneth B Margulies, Anjali Tiku Owens, David S Frankel Atrial Fibrillation in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Real-World Incidence, Management, and Outcomes , Research Letter: JACC Clinical Electrophysiology: 2025
Melissa A Austin, Alejandro de Feria, Nosheen Reza, Anjali Owens Riding the Waves of Novel Therapies in Hypertrophic Cardiomyopathy , JACC Case Reports: 2024
Niccolò Maurizi 1 2, Panagiotis Antiochos 2, Anjali Owens 3, Neal Lakdwala 4, Sara Saberi 5, Mark W Russell 6, Carlo Fumagalli 1 7, Ioannis Skalidis 2, Kimberly Y Lin 8, Ashwin S Nathan 3, Alejandro De Feria Alsina 3, Nosheen Reza 3, John C Stendahl 9, Dominic Abrams 10, Christopher Semsarian 11 12 13, Brian Clagget 14, Rachel Lampert 8, Matthew Wheeler 15, Victoria N Parikh 15, Euan Ashley 15, Michelle Michels 16, Joseph Rossano 8, Thomas D Ryan 17, Jodie Ingles 18, James Ware 19, Carolyn Y Ho 4, Adam S Helms 5, Sharlene M Day # 3, Iacopo Olivotto Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry. , Circulation: 2024
Nosheen Reza, Anandkumar Dubey, Thomas Carattini, Amy Marzolf, Nicole Hornsby, Alejandro de Feria, Nadim Mahmud, Patricia Schuler, Anjali Tiku Owens Real-World Experience and 36-Week Outcomes of Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten , JACC Heart Failure, 12(6): 2024,1123-1125